Definiens Digital Pathology Webinar Announcement: SOX2 Evaluation in NSCLC using Definiens Tissue Studio

From Digital Pathology Insights

Date: June 10^th, 2010

Time: 11am EDT / 4pm GMT

Join us for a webinar: SOX2 Evaluation in Non-small Cell Lung Cancer using Definiens Tissue Studio.

In this talk, a study on SOX2 amplification in non-small cell lung cancer with a special focus on IHC assessment using Definiens Tissue Studio image analysis software will be presented.

The aim of the study was to verify SOX2 amplification and protein over-expression in non-small cell lung cancers (NSCLC) and to compare these results with patient and tumor characteristics. A total of 940 NSCLCs from two independent population-based cohorts containing predominantly adenocarcinomas of the lung and squamous cell lung carcinomas, were assessed by fluorescence in-situ hybridization (FISH) and immunohistochemistry (IHC) to study SOX2 amplification and expression level. For protein expression analysis, the expression level was explored by utilizing Definiens Tissue Studio.

Speakers:

• Sven Perner: Assistant Professor – Institute of Pathology, Comprehensive Cancer Center, University Hospital Tuebingen
• Theresia Wilbertz: PhD Candidate – Institute of Pathology, Comprehensive Cancer Center, University Hospital Tuebingen
• Peter Duncan: Director of Marketing and Business Development – Definiens

Space is limited. Reserve your webinar seat now at:

https://www2.gotomeeting.com/register/654854170